CorMedix (CRMD) Tops Q2 EPS by 2c
CorMedix (NASDAQ: CRMD) reported Q2 EPS of ($0.19), $0.02 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on CorMedix (CRMD) click here.
CorMedix (NASDAQ: CRMD) reported Q2 EPS of ($0.19), $0.02 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on CorMedix (CRMD) click here.